A small but notable number of patients receiving oral anticoagulation will experience a major bleed or require invasive surgery. In these situations, anticoagulation reversal is often essential, but how should reversal be managed in these patients? How should it differ between patients receiving a vitamin K antagonist (VKA), and a non-vitamin K antagonist oral anticoagulant (NOAC)?
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest